CyBio AG: Turnover in first half year increased by 44%. Negative result was caused by set up R&D and production capacities.
Growth in turnover was mainly borne in the field of contract manufacturing. In the last months the serial production for Corning Inc. and CLONDIAG Chip Technologies GmbH starts duly and is generating an important contribution to turnover. Further growth in turnover is also coming from the automation business and proves the trend in industry towards integrated and complete solutions. Stand alone business is stagnating.
Sales regions Germany and Europe performed notably above expectations. Set up the own sales subsidiary in Japan in April 2007 presents first success in turnover. CyBio Japan Co., Ltd reached already a turnover of 250,000 EUR in the second quarter. To meet the growth in turnover the group result was lowered by the planned advance investments, especially in the production, service and R&D.
Our subsidiary CyBio Robotics GmbH (formerly accelab GmbH) has delivered its main project, an automated system for the production of synthetic genes to its customer Sloning BioTechnology GmbH in the last weeks. With this Know-how CyBio achieves access to a new innovative growth market.
Based on the business development so far this year CyBio is confident to achieve the projected turnover 2007. The total invested advanced costs will be affecting the result in 2007.